(Q44017120)

29 November 2017

Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children (English)

1 reference

29 November 2017

1 reference

1 reference

2

MacDonald NE

1 reference

29 November 2017

King WJ

1

1 reference

29 November 2017

Wells G

3

1 reference

29 November 2017

Huang J

4

1 reference

29 November 2017

Allen U

5

1 reference

29 November 2017

Chan F

6

1 reference

29 November 2017

Ferris W

7

1 reference

29 November 2017

Diaz-Mitoma F

8

1 reference

29 November 2017

Ashton F

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

The Journal of Pediatrics

29 November 2017

1 reference

29 November 2017

128

1 reference

29 November 2017

2

1 reference

29 November 2017

196-202

1 reference

Serogroup C meningococcal outbreaks in the United States. An emerging threat

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Human immunity to the meningococcus. I. The role of humoral antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Human immunity to the meningococcus. II. Development of natural immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Kinetics of Antibody Production to Group A and Group C Meningococcal Polysaccharide Vaccines Administered during the First Six Years of Life: Prospects for Routine Immunization of Infants and Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Immune Response of Human Infants to Polysaccharide Vaccines of Groups A and C Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Response of children to Neisseria meningitidis polysaccharide vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Immunogenicity of group A and group C meningococcal polysaccharides in human infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Immunogenicity of the Group A and Group C Meningococcal Polysaccharides in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Meningococcal Disease: Still with Us

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970389-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(96)70389-X

1 reference

29 November 2017

1 reference